Skip to content
Government NSW, Medical Health Aged Care

***MEDIA ALERT*** Ahead of Sydney Drug Summit NSW AOD Providers urge Premier to be courageous and bold

Uniting NSW.ACT 2 mins read

On the eve of the Sydney Drug Summit, and at Uniting’s Medically Supervised Injecting Centre (MSIC) in Kings Cross – the key outcome of the 1999 Drug Summit’s main recommendation - several of the state’s key faith based Alcohol and Other Drug treatment (AOD) service providers will gather for a press conference to express their ardent desire for this event to produce genuine reforms and a guarantee that nothing be taken off the table. 

 

In a joint statement the group has called on the Premier and his government to recognise the ongoing impact stigma has on people who use drugs; the difficulty many experience trying to access treatment; the increasing rates of overdose across the state and the systems and policies that disproportionately harm the most vulnerable in the community.  

 

What:  Press conference 

When: Tuesday 3rd December – arr. 8.15am for 8.30am start

Where: Uniting Medically Supervised Injecting Centre (MSIC), 66 Darlinghurst Road (opp Kings Cross Train station) 

Who:

  • Emma Maiden - Uniting NSW.ACT 
  • Dr Marianne Jauncey - MSIC Medical Director 
  • Rev Stu Cameron - CEO Wesley Mission 
  • Andy Biddle - State Manager, AOD Services, The Salvation Army
  • Jon Owen – Pastor and CEO Wayside Chapel
  • Cara Varian – NCOSS CEO

Emma Maiden, General Manager of Advocacy and External Relations at Uniting NSW.ACT said: “The 2024 Drug Summit is a chance to dream big, just like we did in 1999. We must find solutions that combat stigma and treat people who use drugs as we would want our own children and family members to be treated. 

 

“We want the Drug Summit to result in outcomes and solutions that are: 

  • evidence-based
  • health-focused
  • align with our values
  • keep people safe 
  • do not perpetuate stigma but ensure the best outcomes for people, especially for families, young people, First Nations people, people experiencing disadvantage and rural and regional communities. 

 

“We look forward to working with the New South Wales Government to make this happen. 

 

“The outcomes we would like to see include: 

  • Greater investment in treatment and harm reduction services so that people can access the support they need when they seek it 
  • Dignifying, evidence based and health-focused responses to people’s substance use and dependency.”

 

We can arrange for reporters to speak with a person with lived experience of drug use who will be attending the Drug Summit.

 

Uniting NSW.ACT runs the Medically Supervised Injecting Centre and has spearheaded the Fair Treatment campaign for fairer drug laws for more than five years. 

 

NOTE TO EDITORS: As MSIC functions as a daily service centre we must leave the building by 9.15am sharp to allow normal activities to commence at 9.30am. We would really appreciate your support and understanding regarding this. 

 

About Uniting
Uniting NSW.ACT contributes to the work of the Uniting Church in NSW and the ACT, through social justice advocacy, community services and spiritual care. We provide services for people through all ages and stages of life, and drive solutions to systemic issues so people experiencing disadvantage can live their best lives. Our purpose is to inspire people, enliven communities and confront injustice. We value diversity and always


Contact details:

Bronwen Reed / Jane Garcia
Uniting Media
0481 056 781 / 0432 750 661

Media Phone: 0457 568 938
breed@uniting.org / jgarcia@uniting.org

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.